Facebook
Twitter
Telegram
Report an ErrorSpectrum Pharmaceuticals Financial Statements 2011-2024 | SPPI
Annual Financial Statements Spectrum Pharmaceuticals
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
123 M | 105 M | 447 M | 290 M | 1.16 B | 1.91 B | 327 M | 322 M | 453 M | 523 M | 699 M | 752 M |
Shares |
183 M | 155 M | 124 M | 111 M | 103 M | 85.1 M | 72.8 M | 64.9 M | 64.7 M | 60.7 M | 58.6 M | 53.3 M |
Historical Prices |
0.67 | 0.68 | 3.43 | 2.86 | 10.8 | 21.5 | 6.4 | 4.52 | 6.23 | 8.35 | 11.2 | 14 |
Net Income |
-75.4 M | -159 M | -161 M | -113 M | -120 M | -91.2 M | -68.5 M | -50.8 M | -45.7 M | -62.1 M | 94.5 M | 48.5 M |
Revenue |
10.1 M | - | - | - | 109 M | 128 M | 146 M | 163 M | 187 M | 156 M | 268 M | 193 M |
Cost of Revenue |
1.79 M | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | 82.6 M | 81.1 M | 111 M | 135 M | 160 M | 127 M | 221 M | 159 M |
Operating Income |
-72.7 M | -148 M | -170 M | -141 M | -138 M | -116 M | -62.9 M | -42.6 M | -31.6 M | -38.8 M | 80.8 M | 56.5 M |
Interest Expense |
-5.33 M | -10.9 M | -2.94 M | -8.89 M | 3.13 M | 8.07 M | 9.69 M | 9.21 M | 8.72 M | 217 K | -359 K | 280 K |
EBITDA |
-72.4 M | -147 M | -169 M | -137 M | -103 M | -69 M | -35.7 M | -2.41 M | -7.28 M | -18.7 M | 86.6 M | 58.9 M |
Operating Expenses |
- | - | 170 M | 141 M | 214 M | 178 M | 172 M | 176 M | 191 M | 166 M | 141 M | 104 M |
General and Administrative Expenses |
38.8 M | 60.4 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Spectrum Pharmaceuticals
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
202 M | 203 M | - | 176 M | 170 M | 165 M | 159 M | 155 M | 145 M | 146 M | 131 M | 113 M | 112 M | 113 M | 111 M | 110 M | 110 M | 111 M | 104 M | 103 M | 101 M | 101 M | 83.5 M | 78.6 M | 78.5 M | 80.5 M | 79.3 M | 68.6 M | 65.6 M | 68.2 M | 65.9 M | 65.5 M | 64.9 M | 66 M | 64.8 M | 64.6 M | 63.4 M | 64.1 M | 61.9 M | 59 M | 59.2 M | 60 M | 58.9 M | 58.8 M | 58.5 M | 59.2 M | 53.8 M | 52.3 M | 51.3 M |
Net Income |
-5.01 M | - | - | -29 M | -15.4 M | - | -33.1 M | -50.1 M | -35.7 M | - | -48.5 M | -32.1 M | -40.6 M | -40.2 M | -26 M | -28.4 M | -19.3 M | -53.1 M | -69.2 M | 14.9 M | -19.2 M | -28.6 M | -18.3 M | -20.9 M | -23.5 M | -18.1 M | -17.6 M | -24.5 M | -9.53 M | -4.15 M | -18.7 M | -2.35 M | -25.6 M | -2.98 M | -11.5 M | -3.56 M | -27.6 M | -39.2 M | -7.81 M | -9.72 M | -5.44 M | 7.49 M | 21.5 M | 18.1 M | 46.5 M | 8.28 M | 20.3 M | 7.2 M | 12.8 M |
Revenue |
15.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 30.5 M | 28.6 M | 36.4 M | 34.3 M | 29.1 M | 35.2 M | 33.4 M | 33.9 M | 43.9 M | 50.3 M | 28.6 M | 45 M | 38.6 M | 51.9 M | 48 M | 46.9 M | 40.1 M | 41.5 M | 42.4 M | 33.2 M | 38.7 M | 70.1 M | 69 M | 68.7 M | 59.9 M | 53 M | 51 M | 45.4 M | 43.6 M |
Cost of Revenue |
1.06 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-4.87 M | - | - | -25.4 M | -14.1 M | - | -33.1 M | -44.1 M | -33.7 M | -62.9 M | -39.6 M | -36.5 M | -30.8 M | -38.4 M | -30.3 M | -34.2 M | -37.8 M | -46.5 M | -28.4 M | -33 M | -30 M | -41.1 M | -15.1 M | -18.6 M | -21.9 M | -17.9 M | -16.2 M | -22.3 M | -6.49 M | -2.96 M | -16.1 M | -34 K | -21.7 M | -1.63 M | -4.13 M | -1.4 M | -24.4 M | -6.51 M | -13.3 M | -12.5 M | -6.46 M | 11 M | 23.1 M | 23 M | 23.6 M | 9.66 M | 18 M | 9.92 M | 17.5 M |
Interest Expense |
248 K | - | - | -3.76 M | -1.33 M | - | 9 K | -5.88 M | -2.08 M | - | -9.13 M | 3.94 M | -10.5 M | - | 2.02 M | 3.72 M | -11.3 M | - | 793 K | 886 K | 873 K | - | 2.37 M | 2.32 M | 2.3 M | - | 7.24 M | 4.8 M | 2.38 M | - | -535 K | 69 K | 2.26 M | - | -1.39 M | -487 K | 2.1 M | - | 1.37 M | 234 K | -897 K | - | 293 K | -1.51 M | 138 K | - | -144 K | 174 K | 520 K |
EBITDA |
-4.82 M | - | - | -25.2 M | -14 M | - | -33.1 M | -43.9 M | -33.6 M | -62.9 M | -39.7 M | -36.2 M | -30.6 M | -38.4 M | -28.8 M | -32.8 M | -36.5 M | -46.5 M | -7.42 M | -19 M | -23 M | -41.1 M | 5.91 M | -4.65 M | -14.9 M | -17.9 M | 3.31 M | -9.8 M | -484 K | -2.96 M | 5.16 M | 14.1 M | -14.6 M | -1.63 M | 14.6 M | 10.8 M | -18.4 M | -6.51 M | 2.96 M | -1.76 M | -1.11 M | 11 M | 29.8 M | 27.1 M | 25.3 M | 9.66 M | 22 M | 12.4 M | 18.7 M |
Operating Expenses |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
14 M | - | - | 9.38 M | 9.87 M | - | 12.2 M | 15 M | 14.3 M | - | 15.1 M | 14.7 M | 14.8 M | - | 13.1 M | 17.2 M | 16 M | - | 13.1 M | 16.4 M | 16.6 M | - | 18.5 M | 17.4 M | 19.1 M | - | 19.5 M | 27.6 M | 22 M | - | 19.4 M | 22.6 M | 23.3 M | - | 24.1 M | 25.4 M | 23.4 M | - | 29 M | 22.6 M | 22 M | - | 22.9 M | 23.3 M | 18.3 M | - | 15.8 M | 18.7 M | 12.8 M |
All numbers in USD currency